Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2024

Oct 8, 2024

34395_dirs_2024-10-08_13a85591-e0ff-4214-9890-7109ece2e90f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2024-10-04-05:00

Reporting Person: Batchelor Ann-Louise (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-10-04-05:00 Common Stock F 6110 $0.883 Disposed 101566 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 29406 Indirect

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 13,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.